Prognostic value of ERCC1, ERCC2, XRCC1, and TP53 single nucleotide polymorphisms in patients with early-stage non-small cell lung cancer

Identification of biomarkers used for the prognostic evaluation of non-small cell lung cancer (NSCLC) patients is important. The aim of this study was to evaluate the potential prognostic value of XRCC1, ERCC1, ERCC2, and TP53 single nucleotide polymorphisms (SNPs) in completely resected NSCLC patie...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Tumor biology 2015-06, Vol.36 (6), p.4279-4285
Hauptverfasser:	Geredeli, Caglayan, Artac, Mehmet, Yildirim, Selman, Inal, Ali, Dede, Isa, Guler, Tunc, Boruban, Melih Cem, Koral, Lokman, Karaagac, Mustafa, Zamani, Ayse Gul, Altinok, Tamer, Aribas, Olgun, Bozcuk, Hakan, Demirkazik, Ahmet
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Aged, 80 and over Biomarkers, Tumor - genetics Biomedical and Life Sciences Biomedicine Cancer Research Carcinoma, Non-Small-Cell Lung - drug therapy Carcinoma, Non-Small-Cell Lung - genetics Carcinoma, Non-Small-Cell Lung - pathology Carcinoma, Non-Small-Cell Lung - surgery Disease-Free Survival DNA-Binding Proteins - genetics Endonucleases - genetics Female Gene expression Humans Lung cancer Male Medical prognosis Middle Aged Neoplasm Recurrence, Local - drug therapy Neoplasm Recurrence, Local - genetics Neoplasm Recurrence, Local - pathology Neoplasm Recurrence, Local - surgery Neoplasm Staging Platinum - administration & dosage Polymorphism Polymorphism, Single Nucleotide Prognosis Research Article Tumor Suppressor Protein p53 - genetics X-ray Repair Cross Complementing Protein 1 Xeroderma Pigmentosum Group D Protein - genetics
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!